These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 946698)

  • 21. Suspected chlorpyrifos toxicosis in a llama, and plasma pseudocholinesterase activity in llamas given chlorpyrifos.
    Pearson EG; Craig AM; Lassen ED
    J Am Vet Med Assoc; 1986 Nov; 189(9):1062-4. PubMed ID: 2464570
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum pseudocholinesterase activity in acute myocardial infarction.
    Vachharajani SD; Grover DN
    Indian Heart J; 1976 Jan; 28(1):29-32. PubMed ID: 1032885
    [No Abstract]   [Full Text] [Related]  

  • 23. Pharmacodynamic properties of succinylcholine in greyhounds.
    Curtis MB; Eicker SE
    Am J Vet Res; 1991 Jun; 52(6):898-902. PubMed ID: 1883092
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Physical activity is associated with risk factors for chronic disease across adult women's life cycle.
    Woolf K; Reese CE; Mason MP; Beaird LC; Tudor-Locke C; Vaughan LA
    J Am Diet Assoc; 2008 Jun; 108(6):948-59. PubMed ID: 18502225
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Evaluation of the pseudocholinesterase activity in hyperlipoproteinemia type II and type IV].
    Averna MR; Montalto G; Rini GB; Di Fede G; Labisi M; Marino G; Notarbartolo A
    Boll Soc Ital Biol Sper; 1983 Apr; 59(4):520-4. PubMed ID: 6882547
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Obesity--a risk factor].
    Hlúbik P; Opltová L; Chaloupka J
    Sb Lek; 2002; 103(4):499-509. PubMed ID: 12688165
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Behavior of serum pseudocholinesterase in fasting therapy of obesity].
    Fekete T; Marcu A
    Stud Cercet Med Interna; 1970; 11(4):301-4. PubMed ID: 5474703
    [No Abstract]   [Full Text] [Related]  

  • 28. [Pseudocholinesterase in patients with and without liver diseases (author's transl)].
    Gentz HD; Schlicht I; Wiederholt W
    Med Klin; 1978 Oct; 73(41):1422-6. PubMed ID: 703668
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum pseudocholinesterase activity & protein bound fucose level in oral malignancy.
    Sen R; Sur R; Dasgupta R; Mazumder GC
    Indian J Cancer; 1987 Dec; 24(4):242-50. PubMed ID: 3505513
    [No Abstract]   [Full Text] [Related]  

  • 30. Studies on the metabolism of benoxinate by human pseudocholinesterase.
    Dubbels R; Schloot W
    Metab Pediatr Syst Ophthalmol; 1983; 7(1):37-43. PubMed ID: 6621359
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Behavior of cholinesterase activity in lipid metabolism disorders].
    Reuter W; Geus P
    Z Gesamte Inn Med; 1987 Jul; 42(13):371. PubMed ID: 3630286
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pseudocholinesterase and trait anxiety in premenstrual tension syndrome.
    Giannini AJ; Price WA; Loiselle RH; Giannini MC
    J Clin Psychiatry; 1985 Apr; 46(4):139-40. PubMed ID: 4038979
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Interstrain differences in pseudocholinesterase activity in inbred rats and their genetic determination].
    Shchukin PI
    Zh Obshch Biol; 1974; 35(1):134-9. PubMed ID: 4440249
    [No Abstract]   [Full Text] [Related]  

  • 34. [Oxidative stress and antioxidant defense in alcoholic liver disease and chronic hepatitis C].
    Pár A; Róth E; Rumi G; Kovács Z; Nemes J; Mózsik G
    Orv Hetil; 2000 Jul; 141(30):1655-9. PubMed ID: 10962902
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Susceptibility to leprosy and serum atypical pseudocholinesterase.
    Thomas M; Job CK; Kurian PV
    Int J Lepr Other Mycobact Dis; 1976; 44(3):315-8. PubMed ID: 987994
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of Simvastatin upon serum pseudocholinesterase and plasmatic factor VII.
    Zdrenghea D; Bodizs G; Predescu D; Oprea M; Zdrenghea M
    Rom J Intern Med; 2002; 40(1-4):3-9. PubMed ID: 15526536
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Blood coagulation, fibrinolytic activity and lipid profile in subclinical thyroid disease: subclinical hyperthyroidism increases plasma factor X activity.
    Erem C
    Clin Endocrinol (Oxf); 2006 Mar; 64(3):323-9. PubMed ID: 16487444
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pseudocholinesterase in alloxan-diabetic rats.
    Oresković K; Kunec-Vajić E
    Res Commun Chem Pathol Pharmacol; 1992 Oct; 78(1):117-20. PubMed ID: 1462046
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum pseudocholinesterase levels in the patients of coronary artery disease & their 'normal' first degree relatives.
    Tripathi AK; Sikka KK; Srivastava DK
    Indian Heart J; 1987; 39(1):9-11. PubMed ID: 3450576
    [No Abstract]   [Full Text] [Related]  

  • 40. Serum pseudocholinesterase in acute myocardial infarction.
    Sharma SC; Seth HN
    Indian J Pathol Microbiol; 1978 Jan; 21(1):69-72. PubMed ID: 721218
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.